Navigation Links
DNA Diagnostics Center (DDC), One of the World's Largest DNA Testing Companies, Increases the Identification Power of its DNA Tests by More Than 500%

FAIRFIELD, Ohio, Oct. 21, 2013 /PRNewswire/ -- DDC (DNA Diagnostics Center) and its division, DDC Medical, one of the world's largest providers of DNA tests, announced today that all DNA tests utilizing Short Tandem Repeat (STR) DNA testing technology, including Paternity and Cell Line Authentication testing, will now examine 22 genetic markers versus 17, which until today has been the core standard in the industry.

With the increase in the number of genetic markers used to create unique DNA profiles, DDC and DDC Medical remain at the forefront of human relationship and cell identity testing. The company continues to lead the industry by introducing this upgraded capability at no additional cost or turn-around time to the consumer. Dr. Michael Baird, DDC's Chief Science Officer and the country's first expert to cite DNA in a court of law, says, "This exciting change in our protocol increases DDC's power of a unique DNA signature by more than 5 fold.  By including these additional markers, we continue to provide the most comprehensive test battery available for human identification."

About Dr. Baird:
Dr. Michael Baird, Chief Science Officer of DDC, is considered the country's foremost expert in DNA and paternity testing, and was the first person to testify in a criminal DNA case in the US, and since 1987, has been involved in more than 350 court cases involving DNA and paternity. He is currently the Chair of the Relationship Testing Committee of the AABB responsible for developing standards for paternity testing. Dr. Baird has authored or coauthored over 50 peer reviewed scientific articles involving DNA identification analysis.  He has served as an on-air consultant to NBC, CNN, MSNBC, Fox News and many of the world's leading news outlets. Dr. Baird received his BA in Biology from Drew University in 1971, his MA in Biology from the State University of New York in 1973, and earned his PhD in Genetics from the University of Chicago in 1978.  He was a postdoctoral fellow at the University of Michigan in the department of human genetics where he studied sickle cell anemia, followed by a position as a Research Associate at Columbia University in the department of human genetics.  Dr. Baird served on the panel of the Office of Technology Assessment for the U.S. Congress studying the use of DNA for identification.  He also presented information to the panels of the National Research Council that studied DNA testing methods and issued reports in 1992 and 1996.

About DNA Diagnostics Center (DDC):
DDC is one of the world's largest DNA testing companies. Founded 19 years ago, DDC offers comprehensive DNA testing services for paternity and other family relationships, forensics, cell line authentication, and ancestry. DDC receives more than 800,000 consumer calls each year and performs over half a million tests annually. The Company is known for its groundbreaking technologies, including an exclusive license for the most innovative and accurate non-invasive prenatal paternity test using SNP (single-nucleotide polymorphism) Microarray Technology, which only requires a simple blood draw from the mother and alleged father. DDC's unique Dual Process™ ensures all professionally collected DNA samples are independently tested twice producing legal results of unmatched quality and reliability. DDC is recognized through a number of accreditations nationally and internationally achieving perfect ratings in its past 19 inspections including those performed by the American Association of Blood Banks (AABB) and the College of American Pathologists (CAP). DDC is also accredited by ACLASS to meet the standards of ISO 17025:2005 and the American Society of Crime Laboratory Directors Laboratory Accreditation Board International and follows the DNA Advisory Board (DAB) guidelines, which attests to DDC's superior forensic testing service. For more information: or 1-888-362-3928.

SOURCE DDC (DNA Diagnostics Center)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
2. Life Technologies and Advanced Cell Diagnostics Sign Global Distribution Agreement
3. Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune Disease Diagnostics
4. Indivumed Sells Inostics, the plasma-DNA Company, to Sysmex and Expands its Clinical Research Service and Patient Diagnostics Business
5. Aging to Be Reversed through Revolutionary New Category of Diagnostics
6. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
7. Sorrento Therapeutics Secures Rights to Biomiga Diagnostics Therapeutic Drug Monitoring Device for Development of Personalized Paclitaxel Cancer Therapy
8. Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
9. Advances in Magnetic Resonance Imaging (MRI) Market (2013-2018) -- Technology Trend Analysis -- By Architecture, Field Strengths, Technology & Applications in Medical Diagnostics with Market Landscape Analysis -- Estimates up to 2018
10. ITC Acquires Accumetrics to Form Leading POC Cardiovascular Diagnostics Business
11. MGC Diagnostics Corporation Reports 2013 Third Quarter Operating Results
Post Your Comments:
(Date:11/26/2015)... 26, 2015 --> ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... found that immunotherapy can be efficiently combined with photodynamic ...
(Date:11/26/2015)... SAN FRANCISCO , November 26, 2015 ... 1.82 billion by 2022, according to a new report by ... as Chronic Kidney Disease (CKD) which demands kidney transplantation is ... convenient and cost effective substitute for organ transplantation. --> ... 1.82 billion by 2022, according to a new report by ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology:
(Date:11/27/2015)... Los Angeles, CA (PRWEB) , ... November 27, 2015 , ... ... new study carried out by the University of Toronto and the University of British ... number of hospitalizations for head injuries. The article explains that part of the reason ...
(Date:11/27/2015)... ... 2015 , ... "When I was traveling, I was very ... "Many people catch diseases simply from sitting on such dirty toilet seats. I ... germs." , He developed the patent-pending QUDRATECS to eliminate the need to sit ...
(Date:11/27/2015)... ... 27, 2015 , ... Consistent with the Radiology Business ... Better Radiology Marketing Programs meeting will showcase some of the best 2015 ... Caesars Palace in Las Vegas with a pre-conference session on a collaborative approach ...
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
Breaking Medicine News(10 mins):